CSTL
Castle Biosciences, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$23.89-1.10%
Price as of Jul 20, 2026
CSTL profitability
Castle Biosciences, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 77.1%
- EBITDA margin
- -0.2%
- EBIT margin
- -9.8%
- Net margin
- -3.8%
- Free cash flow margin
- 1.3%
Returns
- Return on equity
- -2.8%
- Return on assets
- -2.3%
- Return on invested capital
- -6.7%
- Asset turnover
- 0.60x
Cash efficiency
- Cash from operations
- $48.3M
- Cash per share
- $8.63
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.